Epilepsy Foundation's video: Radiprodil a NR2B-NMDA Negative Allosteric Modulator for GRIN-Related Disorder

@Radiprodil, a NR2B-NMDA Negative Allosteric Modulator, for GRIN-Related Disorder

Radiprodil, a NR2B-NMDA Negative Allosteric Modulator, for GRIN-Related Disorder Caused by Gain of Function Mutations: GRIN Therapeutics. Pierandrea Muglia, MD, President & Founder, GRIN Therapeutics, Session IX: Clinical Drugs. For additional sessions, visit https://www.epilepsy.com/pipeline2022 and https://www.epilepsy.com/newsandstories.

Epilepsy Foundation

Subscribers
18.4K

Total Post
0.9K

Total Views
41K

Avg. Views
553.6

View Profile

This video was published on 2022-07-21 23:05:58 GMT by @Epilepsy-Foundation on Youtube. Epilepsy Foundation has total 18.4K subscribers on Youtube and has a total of 0.9K video.This video has received 0 Likes which are lower than the average likes that Epilepsy Foundation gets . @Epilepsy-Foundation receives an average views of 553.6 per video on Youtube.This video has received 0 comments which are lower than the average comments that Epilepsy Foundation gets . Overall the views for this video was lower than the average for the profile.

Epilepsy Foundation's video: Radiprodil a NR2B-NMDA Negative Allosteric Modulator for GRIN-Related Disorder

Other post by @Epilepsy Foundation